FULC logo

Fulcrum Therapeutics (FULC) EBIT

Annual EBIT

-$19.83 M
+$90.83 M+82.08%

December 1, 2024


Summary


Performance

FULC EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFULCprofitabilitymetrics:

Quarterly EBIT

-$19.43 M
+$3.63 M+15.76%

December 31, 2024


Summary


Performance

FULC Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFULCprofitabilitymetrics:

TTM EBIT

-$19.83 M
+$8.56 M+30.15%

December 31, 2024


Summary


Performance

FULC TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFULCprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

FULC EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+82.1%+30.6%+82.1%
3 y3 years+75.5%+30.6%+82.1%
5 y5 years+76.5%+30.6%+82.1%

FULC EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+82.3%-137.0%+43.3%at high+82.6%
5 y5-yearat high+82.3%-137.0%+43.3%at high+82.6%
alltimeall timeat high+82.3%-137.0%+47.8%-171.3%+82.6%

Fulcrum Therapeutics EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-
-$19.43 M(-15.8%)
-$19.83 M(-30.2%)
Dec 2024
-$19.83 M(-82.1%)
-
-
Sep 2024
-
-$23.06 M(-143.9%)
-$28.40 M(-13.4%)
Jun 2024
-
$52.49 M(-275.9%)
-$32.77 M(-70.9%)
Mar 2024
-
-$29.83 M(+6.6%)
-$112.56 M(+1.7%)
Dec 2023
-$110.66 M(-1.3%)
-$27.99 M(+2.0%)
-$110.66 M(-0.0%)
Sep 2023
-
-$27.44 M(+0.5%)
-$110.68 M(+3.3%)
Jun 2023
-
-$27.29 M(-2.3%)
-$107.13 M(-6.1%)
Mar 2023
-
-$27.94 M(-0.3%)
-$114.08 M(+1.7%)
Dec 2022
-$112.13 M(+38.3%)
-$28.01 M(+17.2%)
-$112.13 M(+4.1%)
Sep 2022
-
-$23.89 M(-30.2%)
-$107.68 M(+3.0%)
Jun 2022
-
-$34.23 M(+31.7%)
-$104.56 M(+16.2%)
Mar 2022
-
-$26.00 M(+10.4%)
-$90.01 M(+11.0%)
Dec 2021
-$81.05 M
-$23.56 M(+13.4%)
-$81.05 M(+7.7%)
Sep 2021
-
-$20.77 M(+5.5%)
-$75.28 M(+2.3%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$19.68 M(+15.5%)
-$73.62 M(+5.4%)
Mar 2021
-
-$17.04 M(-4.2%)
-$69.86 M(-2.4%)
Dec 2020
-$71.61 M(-15.0%)
-$17.79 M(-6.9%)
-$71.61 M(+1.8%)
Sep 2020
-
-$19.10 M(+20.0%)
-$70.31 M(+3.1%)
Jun 2020
-
-$15.92 M(-15.3%)
-$68.22 M(+3.7%)
Mar 2020
-
-$18.80 M(+14.0%)
-$65.79 M(-21.9%)
Dec 2019
-$84.22 M(+151.4%)
-$16.49 M(-3.0%)
-$84.22 M(+9.4%)
Sep 2019
-
-$17.01 M(+26.0%)
-$76.98 M(+11.5%)
Jun 2019
-
-$13.49 M(-63.8%)
-$69.06 M(+8.9%)
Mar 2019
-
-$37.23 M(+302.4%)
-$63.41 M(+89.3%)
Dec 2018
-$33.50 M(+45.7%)
-$9.25 M(+1.8%)
-$33.50 M(+38.2%)
Sep 2018
-
-$9.09 M(+15.8%)
-$24.25 M(+60.0%)
Jun 2018
-
-$7.85 M(+7.4%)
-$15.16 M(+107.4%)
Mar 2018
-
-$7.31 M
-$7.31 M
Dec 2017
-$22.99 M
-
-

FAQ

  • What is Fulcrum Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Fulcrum Therapeutics?
  • What is Fulcrum Therapeutics annual EBIT year-on-year change?
  • What is Fulcrum Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Fulcrum Therapeutics?
  • What is Fulcrum Therapeutics quarterly EBIT year-on-year change?
  • What is Fulcrum Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Fulcrum Therapeutics?
  • What is Fulcrum Therapeutics TTM EBIT year-on-year change?

What is Fulcrum Therapeutics annual earnings before interest & taxes?

The current annual EBIT of FULC is -$19.83 M

What is the all time high annual EBIT for Fulcrum Therapeutics?

Fulcrum Therapeutics all-time high annual earnings before interest & taxes is -$19.83 M

What is Fulcrum Therapeutics annual EBIT year-on-year change?

Over the past year, FULC annual earnings before interest & taxes has changed by +$90.83 M (+82.08%)

What is Fulcrum Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of FULC is -$19.43 M

What is the all time high quarterly EBIT for Fulcrum Therapeutics?

Fulcrum Therapeutics all-time high quarterly earnings before interest & taxes is $52.49 M

What is Fulcrum Therapeutics quarterly EBIT year-on-year change?

Over the past year, FULC quarterly earnings before interest & taxes has changed by +$8.56 M (+30.59%)

What is Fulcrum Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of FULC is -$19.83 M

What is the all time high TTM EBIT for Fulcrum Therapeutics?

Fulcrum Therapeutics all-time high TTM earnings before interest & taxes is -$7.31 M

What is Fulcrum Therapeutics TTM EBIT year-on-year change?

Over the past year, FULC TTM earnings before interest & taxes has changed by +$90.83 M (+82.08%)